| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 203 | 2.134 | 4.403 | 4.501 | 4.269 | 24.827 | 15.609 |
| Total Income - EUR | 0 | 0 | 0 | 3.293 | 8.099 | 22.615 | 4.759 | 3.466 | 22.050 | 13.808 |
| Total Expenses - EUR | 630 | 2.859 | 2.715 | 9.636 | 9.668 | 11.759 | 7.298 | 5.349 | 13.121 | 13.319 |
| Gross Profit/Loss - EUR | -630 | -2.859 | -2.715 | -6.344 | -1.569 | 10.856 | -2.539 | -1.883 | 8.929 | 489 |
| Net Profit/Loss - EUR | -630 | -2.859 | -2.715 | -6.347 | -1.633 | 10.576 | -2.584 | -1.928 | 7.529 | 423 |
| Employees | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Cosmeceutica Laboratories Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 153 | 807 | 2.015 | 2.485 | 2.379 | 615 | 0 | 0 | 0 | 0 |
| Current Assets | 50 | 16 | 2.741 | 10.576 | 17.720 | 20.217 | 22.101 | 20.525 | 17.406 | 18.814 |
| Inventories | 0 | 0 | 2.704 | 10.567 | 16.977 | 19.408 | 20.251 | 18.606 | 15.466 | 11.939 |
| Receivables | 0 | 0 | 0 | 0 | 355 | 510 | 1.546 | 561 | 134 | 820 |
| Cash | 50 | 16 | 36 | 9 | 388 | 300 | 304 | 1.358 | 1.806 | 6.055 |
| Shareholders Funds | -585 | -3.437 | -6.094 | -12.330 | -13.713 | -2.877 | -5.398 | -7.343 | 209 | 630 |
| Social Capital | 45 | 45 | 44 | 43 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 787 | 4.260 | 10.850 | 25.391 | 33.812 | 23.709 | 27.499 | 27.868 | 17.198 | 18.184 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2042 - 2042" | |||||||||
| CAEN Financial Year |
2042
|
|||||||||
Comments - Cosmeceutica Laboratories Srl